Efficacy and Safety on Prouk for STEMI Patients in China

Summary

The purpose of the study is to evaluate the efficacy and safety of rh-prouk as pharmacoinvasive therapy on those ST Elevated Myocardial Infarctions patients, it is designed as a multicenter, active controlled, single blinded study. The primary endpoint is to assess the coronary recanalization 90 minutes after thrombolysis. The secondary endpoint is to evaluate the mortality rate at day 30.

Timeline

Start

2015-01

Primary completion

2016-12

Completion

2017-12

Drugs

Indications